•
Oct 02, 2021

Thermo Fisher Q3 2021 Earnings Report

Thermo Fisher Scientific reported an increase in revenue and adjusted EPS for the third quarter of 2021, driven by strong performance across its business segments.

Key Takeaways

Thermo Fisher Scientific reported a 9% increase in revenue to $9.33 billion for the third quarter of 2021. GAAP diluted EPS was $4.79, and adjusted EPS was $5.76. The company is raising its 2021 revenue and earnings guidance.

Third quarter revenue increased 9% to $9.33 billion.

Third quarter GAAP diluted earnings per share (EPS) was $4.79.

Third quarter adjusted EPS was $5.76.

The company is raising its revenue guidance by $1.2 billion to $37.1 billion and its adjusted EPS guidance by $1.30 to $23.37 for 2021.

Total Revenue
$9.33B
Previous year: $8.52B
+9.5%
EPS
$5.76
Previous year: $5.63
+2.3%
Organic Revenue Growth
7%
Adjusted Operating Margin
29.8%
Previous year: 32.9%
-9.4%
Gross Profit
$4.8B
Previous year: $4.46B
+7.7%
Cash and Equivalents
$12B
Previous year: $7.54B
+59.5%
Free Cash Flow
$2.13B
Previous year: $2.34B
-9.1%
Total Assets
$73.6B
Previous year: $64.1B
+14.9%

Thermo Fisher

Thermo Fisher

Thermo Fisher Revenue by Segment

Forward Guidance

Thermo Fisher is raising its 2021 revenue and earnings guidance.

Positive Outlook

  • Raising revenue guidance by $1.2 billion to $37.1 billion.
  • This would result in 15% revenue growth over 2020.
  • Raising adjusted EPS guidance by $1.30 to $23.37.
  • This would represent 20% growth year over year.
  • On track to deliver another outstanding year and set the company up for an even brighter future.

Revenue & Expenses

Visualization of income flow from segment revenue to net income